CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-13 | Patel Sanj K CHAIRMAN & CEO | Gift | +60,000 | 60,000 | ||
| 2025-11-12 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +19,900 | $30.93 | $616K | 50,986 |
| 2025-11-12 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −19,900 | $40.94 | $815K | 31,086 |
| 2025-11-12 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −19,900 | 0 | ||
| 2025-11-12 | Patel Sanj K CHAIRMAN & CEO | Gift | −111,794 | 0 | ||
| 2025-11-12 | Patel Sanj K CHAIRMAN & CEO | Gift | +111,794 | 111,794 | ||
| 2025-10-31 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +36,542 | $3.80 | $139K | 97,866 |
| 2025-10-31 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +46,000 | $8.83 | $406K | 143,866 |
| 2025-10-31 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −82,542 | $37.14 | $3.1M | 61,324 |
| 2025-10-31 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −36,542 | 0 | ||
| 2025-10-31 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −46,000 | 0 | ||
| 2025-10-28 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +100 | $30.93 | $3K | 31,186 |
| 2025-10-28 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −100 | $41.00 | $4K | 31,086 |
| 2025-10-28 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −100 | 19,900 | ||
| 2025-10-22 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +97,390 | $3.80 | $370K | 209,184 |
| 2025-10-22 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −97,390 | $38.83 | $3.8M | 111,794 |
| 2025-10-22 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −97,390 | 0 | ||
| 2025-10-21 | Patel Sanj K CHAIRMAN & CEO | Option exercise 10b5-1 | +39,331 | $3.80 | $149K | 151,125 |
| 2025-10-21 | Patel Sanj K CHAIRMAN & CEO | Sale 10b5-1 | −39,331 | $38.77 | $1.5M | 111,794 |
| 2025-10-21 | Patel Sanj K CHAIRMAN & CEO | Option exercise · Share Option 10b5-1 | −39,331 | 97,390 |
Page 20 of 74 · 1,467 trades